Need more? Try out  Advanced Search (20+ criteria)»

Last Update

is this you? Claim your profile.

Wrong Pipasha Biswas?

Pipasha Biswas

Executive Director and QPPV

Symogen Limited

Direct Phone: +44 **** ******direct phone

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Symogen Limited

33 Wood Avenue South

Iselin, New Jersey,08830

United States

Company Description

Symogen is a niche service provider for all aspects of Pharmacovigilance, Pharmacoepidemiology, Medical Writing & Regulatory Services. Established in 2007, our clients are large and midsize pharmaceutical and biotech companies. Symogen Limited is 9001:2008 (... more.

Find other employees at this company (22)

Background Information

Employment History

Director, Safety Evaluation and Risk Management, Global Clinical Safety and Pharmacovigilance

GlaxoSmithKline plc


Executive Director

Amgen Inc.


Affiliations

Royal College of Physicians

Member of the International Committee


British Association of Research Quality Assurance

Member


International Society for Pharmacoepidemiology

Member


ISoP Secretariat Ltd

Member


Drug Safety Research Unit

Chairperson, Committee


London , UK

Chairperson, Special Interest Network Consultation Committee for Drug Safety and Pharmacovigilance, Faculty of Pharmaceutical Medicine


British Association of Regulatory and Quality Assurance

Member


Education

MD

Medicine and DM

University of Southampton , UK


Web References(41 Total References)


About Us - Symogen Pharmacovigilance Services

www.symogenlimited.com [cached]

Dr Pipasha Biswas Executive Director & QPPV
Dr Pipasha Biswas - Executive Director & QPPV Dr. Pipasha Biswas is currently Principal Consultant, Director & QPPV of Symogen Ltd. She has been involved in pharmacovigilance & pharmacoepidemiology for the last 18 years in Europe, USA and India. Dr. Pipasha Biswas has worked in a number of MNCs in Pharmacovigilance as Executive Director and Lead for Safety Signal detection at Global Drug Safety at Amgen Inc based in California, where she lead the safety signal detection team in global safety. In the UK, she worked as Director, Safety Evaluation and Risk Management, Global Clinical Safety and Pharmacovigilance at GSK, London, where she was the lead physician responsible for Respiratory and Anti-inflammatory therapeutic area. Prior to working at GSK, she was EU Senior Pharmacovigilance Physician at the European Office of Global Safety Surveillance and Epidemiology at Wyeth Europa, based in the UK. Before moving to the pharmaceutical industry, she was Clinical Research Fellow at the Drug Safety Research Unit, based in Southampton, where she conducted large studies in post marketing surveillance. She also has considerable experience in Clinical Research and Clinical Drug Development, having worked at the Department of Vascular Medicine, King's College of Medicine & Dentistry, where she was responsible for conducting clinical trials in Deep Vein Thrombosis patients from phase II to III. She qualified in Medicine from India and trained in Internal Medicine & Cardiology and did her post graduation in Pharmaceutical Medicine, from University of Surrey, UK. She then specialized in Pharmacovigilance & Pharmacoepidemiology from London School of Hygiene and Tropical Medicine, London and then did her DM in Pharmacoepidemiology from University of Southampton, UK. She is the Member of British Association of Research and Quality Assurance (BARQA), International Society of Pharmacovigilance (ISOP) and International Society of Pharmacoepidemiology (ISPE). She has been conferred with the Membership of The Faculty of Pharmaceutical Medicine (Distinction), UK from The Faculty of Pharmaceutical Medicine, The Royal College of Physicians, London. She is the member of the International Committee and Professional Standards Committee at the Faculty of Pharmaceutical Medicine of The Royal College of Physicians, London.


www.symogenlimited.com

Symogen has an impeccable reputation for excellent customer services and extremely ethical and high quality of work under the leadership of Dr Pipasha Biswas.
Dr Pipasha Biswas Dr. Pipasha Biswas is currently Principal Consultant, Director & QPPV of Symogen Ltd. She has been involved in pharmacovigilance & pharmacoepidemiology for the last 18 years in Europe, USA and India. -- More Info -- Dr. Pipasha Biswas has worked in a number of MNCs in Pharmacovigilance as Executive Director and Lead for Safety Signal detection at Global Drug Safety at Amgen Inc based in California, where she lead the safety signal detection team in global safety. In the UK, she worked as Director, Safety Evaluation and Risk Management, Global Clinical Safety and Pharmacovigilance at GSK, London, where she was the lead physician responsible for Respiratory and Anti-inflammatory therapeutic area. Prior to working at GSK, she was EU Senior Pharmacovigilance Physician at the European Office of Global Safety Surveillance and Epidemiology at Wyeth Europa, based in the UK. Before moving to the pharmaceutical industry, she was Clinical Research Fellow at the Drug Safety Research Unit, based in Southampton, where she conducted large studies in post marketing surveillance. She also has considerable experience in Clinical Research and Clinical Drug Development, having worked at the Department of Vascular Medicine, King's College of Medicine & Dentistry, where she was responsible for conducting clinical trials in Deep Vein Thrombosis patients from phase II to III. She qualified in Medicine from India and trained in Internal Medicine & Cardiology and did her post graduation in Pharmaceutical Medicine, from University of Surrey, UK. She then specialized in Pharmacovigilance & Pharmacoepidemiology from London School of Hygiene and Tropical Medicine, London and then did her DM in Pharmacoepidemiology from University of Southampton, UK. She is the Member of British Association of Research and Quality Assurance (BARQA), International Society of Pharmacovigilance (ISOP) and International Society of Pharmacoepidemiology (ISPE). She has been conferred with the Membership of The Faculty of Pharmaceutical Medicine (Distinction), UK from The Faculty of Pharmaceutical Medicine, The Royal College of Physicians, London. She is the member of the International Committee and Professional Standards Committee at the Faculty of Pharmaceutical Medicine of The Royal College of Physicians, London.


www.recunnect.com

Pipasha Biswas
Director & QPPV Symogen Limited Dr. Pipasha Biswas qualified in Internal Medicine/Cardiology and spent 5 years in clinical practice. She then moved to Pharmacovigilance working in increasing roles for the last 20 years at various organisations including Drug Safety Research Unit, Wyeth Europe, GSK and Amgen. Currently she is Executive Director & QPPV at Symogen, which is an internal service provider to pharmaceutical companies in the field of pharmacovigilance, pharmacoepidemiology, medical writing and regulatory affairs. She is the Chairperson for SIN for Pharmacovigilance and Director of CPD at The Faculty of Pharmaceutical Medicine.more


News & Events - Symogen Pharmacovigilance Company

www.symogenlimited.com [cached]

Dr. Pipasha Biswas from Symogen will be speaking at this conference on the following topics:
Pipasha Biswas, Director & QPPV, Pharmacovigilance & Pharmacoepidemiology,Symogen Dr. Pipasha Biswas from Symogen will present the topic "Challenges in Signal Detection and Management" at the 2nd Pharmacovigilance Conference 2016, 14-15 June 2016 London, United Kingdom: Dr. Pipasha Biswas, Executive Director and QPPV, SYMOGEN Limited speaking on From Signal management to Product Labelling at World Drug Safety Congress 2015 at Chicago. Symogen DIA May 4th Pharmacovigilance, Drug Safety & Risk Management Conference, 11-12 May 2015 Dr. Pipasha Biswas Executive Director & QPPV will be Chairing and speaking on "Cause & Effect - Striving Towards Proactive Surveillance Through Innovation" at the 4th Pharmacovigilance, Drug Safety & Risk Management Conference 11-12 May 2015 at Holiday Inn Regents Park Hotel, London. Dr. Pipasha Biswas, Signal Management to Preparation of Product Labels at the World Drug Safety Congress America 2015 SYMOGEN, one of the world's leading pharmacovigilance service providers is pleased to announce that Dr. Pipasha Biswas, Executive Director at SYMOGEN, will speak Signal Management to Preparation of Product Labels at the World Drug Safety Congress America 2015, 22-23 April.


Virtue Insight - Pharma : 4th Annual Pharma Anti-Counterfeiting 2015

www.virtueinsight.com [cached]

Pipasha Biswas
PIPASHA BISWAS, Director, Symogen PIPASHA BISWAS, Director, Symogen Pipasha Biswas Director Symogen Dr. Pipasha Biswas is currently Executive Director & QPPV of Symogen Ltd, UK, an international service provider in Pharmacovigilance, Pharmacoepidemiology, Medical Writing and Regulatory Affairs worldwide. She has been involved in pharmacovigilance for the last 20 years in Europe, USA and India. She has worked in a number of MNCs in Pharmacovigilance as Executive Medical Director and Lead for Safety Signal detection at Global Drug Safety at Amgen Inc based in California, where she lead the safety signal detection team in global safety. In the UK, she worked as Medical Director, Safety Evaluation and Risk Management, Global Clinical Safety and Pharmacovigilance at GSK, where she was the lead physician responsible for Respiratory and Antiinflammatory therapeutic area. Prior to working at GSK, London, she was EU Senior Pharmacovigilance Physician at the European Office of Global Safety Surveillance and Epidemiology at Wyeth Europa, based in the UK. Before moving to the pharmaceutical industry, she was Clinical Research Fellow at the Drug Safety Research Unit, based in Southampton, where she conducted large studies in post marketing surveillance,pharmacoepidemiology and signal detection activities. She also has considerable experience in Clinical Research and Clinical Drug Development, having worked at the Department of Vascular Medicine, King's College of Medicine & Dentistry, where she was responsible for conducting clinical trials in Deep Vein Thrombosis patients from phase II to III. She qualified in Medicine from India and trained in Internal Medicine & Cardiology and did her post graduation in Pharmaceutical Medicine, from University of Surrey, UK. She then specialized in Pharmacovigilance & Pharmacoepidemiology from London School of Hygiene and Tropical Medicine, London and then did her MD in Medicine and DM in Pharmacoepidemiology from University of Southampton, UK. She is the Member of British Association of Regulatory and Quality Assurance (BARQA), International Society of Pharmacovigilance (ISOP) and International Society of Pharmacoepidemiology (ISPE). She has been conferred with the Membership of The Pipasha Biswas, Symogen


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory